- Home
- KYMR vs FIVN Comparison
KYMR vs FIVN Comparison
Compare KYMR & FIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- FIVN
- Stock Information
- Founded
- KYMR 2015
- FIVN 2001
- Country
- KYMR United States
- FIVN United States
- Employees
- KYMR N/A
- FIVN N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- FIVN EDP Services
- Sector
- KYMR Health Care
- FIVN Technology
- Exchange
- KYMR Nasdaq
- FIVN Nasdaq
- Market Cap
- KYMR 2.6B
- FIVN 2.8B
- IPO Year
- KYMR 2020
- FIVN 2014
- Fundamental
- Price
- KYMR $40.61
- FIVN $37.39
- Analyst Decision
- KYMR Buy
- FIVN Strong Buy
- Analyst Count
- KYMR 15
- FIVN 17
- Target Price
- KYMR $55.60
- FIVN $58.18
- AVG Volume (30 Days)
- KYMR 532.1K
- FIVN 947.8K
- Earning Date
- KYMR 02-20-2025
- FIVN 02-19-2025
- Dividend Yield
- KYMR N/A
- FIVN N/A
- EPS Growth
- KYMR N/A
- FIVN N/A
- EPS
- KYMR N/A
- FIVN N/A
- Revenue
- KYMR $87,563,000.00
- FIVN $1,002,340,000.00
- Revenue This Year
- KYMR N/A
- FIVN $15.54
- Revenue Next Year
- KYMR $33.16
- FIVN $10.46
- P/E Ratio
- KYMR N/A
- FIVN N/A
- Revenue Growth
- KYMR 86.92
- FIVN 13.93
- 52 Week Low
- KYMR $26.92
- FIVN $26.60
- 52 Week High
- KYMR $53.27
- FIVN $81.24
- Technical
- Relative Strength Index (RSI)
- KYMR 47.90
- FIVN 37.33
- Support Level
- KYMR $40.20
- FIVN $37.01
- Resistance Level
- KYMR $44.34
- FIVN $38.60
- Average True Range (ATR)
- KYMR 2.58
- FIVN 1.36
- MACD
- KYMR 0.29
- FIVN -0.55
- Stochastic Oscillator
- KYMR 57.47
- FIVN 18.03
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.